CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington¿s disease
Our research is devoted to the study of the molecular mechanisms of cell death and proliferation, as they are involved in the development of different human pathologies.